Cellular Localization, Binding Sites, and Pharmacologic Effects of TFF3 in Experimental Colitis in Mice
- 229 Downloads
Trefoil factors (TFFs) are essential for protection and restitution of the gastrointestinal mucosa but many aspects of TFF biology are unclear. Our aim was to compare the localization of endogenous TFFs and binding sites for injected TFF3 in the colon of healthy and colitic mice and to study the effect of TFF3 on dextrane sulfate sodium (DSS)-induced colitis in mice. Expression of endogenous TFF1-3 was examined by in situ hybridization and immunohistochemistry, and the distribution of intravenously, intraperitoneally, and subcutaneously administered 125I-TFF3 by autoradiography and gamma-counting. The effect of systemically administered TFF3 on DSS-induced colitis was assessed. We found increased expression of endogenous TFF3 and increased binding of injected 125I-TFF3 in the colon of animals with DSS-induced colitis. The distribution of intraperitoneally and subcutaneously administered 125I-TFF3 was comparable. Systemic administration of the peptides reduced the severity of colitis. Expression of endogenous TFF3 and binding of systemically administered TFF3 are increased in DSS-induced colitis. Systemic administration of TFF3 attenuates the disease. These findings suggest a role of TFF3 in mucosal protection.
KeywordsAnimal models Autoradiography Dextran sulfate sodium Experimental colitis Inflammatory bowel disease Intestinal trefoil factor TFF3
S. Kjellev was supported by a student fellowship from the Danish Ministry for Science, Technology and Innovation. The authors are grateful to the Danish Ministry of Science, Technology and Development and the Danish Research Council for financial support of this study. We thank Grazyna Poulsen, Jette Schousboe, Axel K. Hansen, Bjørg Harryson, Jette Mandelbaum, Steen Kryger, Ann-Christin Løff, and Bodil E. Andersen.
- 3.Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA (1995) Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 175:405–414PubMedCrossRefGoogle Scholar
- 16.Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, Heath JK, Ernst M (2002) Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8:1089–1097PubMedCrossRefGoogle Scholar
- 34.Byrne FR, Farrell CL, Aranda R, Rex KL, Scully S, Brown HL, Flores SA, Gu LH, Danilenko DM, Lacey DL, Ziegler TR, Senaldi G (2002) RHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 282:G690–G701PubMedGoogle Scholar
- 35.Renes IB, Verburg M, Van Nispen DJPM, Taminiau JaJM, Buller HA, Dekker J, Einerhand AWC (2002) Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int J Colorect Dis 17:317–326CrossRefGoogle Scholar
- 40.Efstathiou JA, Noda M, Rowan A, Dixon C, Chinery R, Jawhari A, Hattori T, Wright NA, Bodmer WF, Pignatelli M (1998) Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci USA 95:3122–3127PubMedCrossRefGoogle Scholar
- 43.Rodrigues S, Van Aken E, Van Bocxlaer S, Attoub S, Nguyen QD, Bruyneel E, Westley BR, May FE, Thim L, Mareel M, Gespach C, Emami S (2003) Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 17:7–16PubMedCrossRefGoogle Scholar